---
title: "NAMSW.US (NAMSW.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NAMSW.US/news.md"
symbol: "NAMSW.US"
name: "NAMSW.US"
parent: "https://longbridge.com/en/quote/NAMSW.US.md"
datetime: "2026-03-14T19:15:22.453Z"
locales:
  - [en](https://longbridge.com/en/quote/NAMSW.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NAMSW.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NAMSW.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/NAMSW.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NAMSW.US/news.md)


# NAMSW.US (NAMSW.US) — Related News

### [Newamsterdam Pharma - CW27 | 8-K: FY2025 Revenue: USD 22.5 M](https://longbridge.com/en/news/276224124.md)
*2026-02-18T12:02:13.000Z*
### [Newamsterdam Pharma - CW27 | 10-Q: FY2025 Q3 Revenue: USD 348 K](https://longbridge.com/en/news/264442264.md)
*2025-11-05T13:04:38.000Z*
### [Newamsterdam Pharma - CW27 | 8-K: FY2025 Q3 Revenue: USD 348 K](https://longbridge.com/en/news/264441873.md)
*2025-11-05T13:03:18.000Z*
### [Newamsterdam Pharma - CW27 | 10-Q: FY2025 Q2 Revenue: USD 19.15 M](https://longbridge.com/en/news/251813891.md)
*2025-08-06T11:01:36.000Z*
### [Newamsterdam Pharma - CW27 | 8-K: FY2025 Q2 Revenue: USD 19.15 M](https://longbridge.com/en/news/251813839.md)
*2025-08-06T11:01:29.000Z*
### [Newamsterdam Pharma - CW27 | 10-Q: FY2025 Q1 Revenue: USD 2.978 M](https://longbridge.com/en/news/239343219.md)
*2025-05-08T12:02:56.000Z*
### [Newamsterdam Pharma - CW27 | 8-K: FY2025 Q1 Revenue: USD 2.978 M](https://longbridge.com/en/news/239342517.md)
*2025-05-08T12:01:24.000Z*